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INTRODUCTION 
Preterm birth is defined as birth before 37 weeks gestation. The incidence 
is 6-10% of all births. It is the major cause for neonatal morbidity and mortality. 
The incidence of spontaneous preterm birth was about three quarters of all 
preterm births. 
Inspite of recent advances in neonatal care, the preterm birth may not be 
easily predictable from the patient’s obstetric history or from routine pervaginal 
examination. Several studies showed dispropotionate shortening of cervical 
canal length is a useful predictor of preterm delivery. 
The diagnosis of preterm labor remains unreliable, resulting in significant 
overtreatment. Only fewer than 10% of these women deliver within 1 week. 
So, it would be of great clinical importance to find markers which help to 
find out the pregnant women with preterm uterine contraction, who end up with 
preterm delivery. They might be benefitted from timely admission and 
appropriate treatment. 
There are many investigations which evaluate many substances that have 
been found in cervical and vaginal fluids for their ability to predict spontaneous 
preterm birth. 
Insulin-like growth factor binding protein-1 is one of the secretory 
proteins of decidualised endometrium. It was formerly known as placental 
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protein 12. It has 2 forms, phosphorylated and dephosphorylated. The 
phosphorylated isoform predominantly seen in decidual cells and liver 
When the delivery is approaching fetal membranes begin to detach from 
decidua paritalis. The phosphorylated IGFBP-I leaks in to cervical secretion of 
symptomatic women is a good marker for prediction of preterm delivery 
In this study we evaluate , whether patient with preterm labor with intact 
membranes have phosphorylated IGFBP-I in their cervical secretion and 
increased level of this marker are associated with an increased risk of preterm 
delivery within next 7-10 days. Also we evaluate the cervical length 
measurement and phIGFBP-1 association for predicting preterm delivery. 
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AIM OF THE STUDY 
To assess the  efficacy of insulin like growth factor binding protein 1 and 
cervical length  at first admission in  symptomatic women with intact 
membranes for the prediction of impending preterm delivery. 
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MATERIALS AND METHODS 
             This is a prospective study of 100 antenatal women, who 
presented to labor ward, INSTITUTE OF OBSTETRICS AND 
GYNECOLOGY, MMC, CHENNAI in a time period between  JAN 2014 To 
AUG 2014. Ethical committee clearance was obtained from the institution to 
undergo this study. 
            After getting the consent all women were examined. Detailed 
obstetrics history and general examination was done. Per abdominal 
examination followed by sterile speculum examination done. Any draining pv 
or signs of infection were noted. We took cervical swab for a quantitative assay 
of ph-IGFBP-I. The swab was kept in the cervix for 15 seconds. 
          Then the swab was kept in the test tube containing 0.5 ml of 
extraction buffer. The specimen was extracted immediately from the swab by 
swirling the swab vigorously in the solution for 15 secs. Press the swab against 
the wall of the specimen extraction solution tube. Swab was discarded after that. 
   Insulin like growth factor binding protein-I was measured in cervical 
swab Samples obtained using immunoenzymometric assay by bedside kit 
Value more than 10 microgram/lit considered as positive. It is shown as 
two dark line in the bedside kit.The cervical length was measured by 
transvaginal ultrasound. 
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Then the patient was followed for next 10 days to till delivery  by phone or 
clinical visit. 
INCLUSION CRITERIA 
All symptomatic woman with intact membrane, less than 37 weeks of gestation 
and less than 3 cm cervical dilatation. 
EXCLUSION CRITERIA 
 Patient refusal 
 Multiple gestation  
 Previous caesarean section 
 Preeclampsia 
 Gestational diabetes mellitus 
 Anomalous uterus  
 Anomalous babies  
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REVIEW OF LITERATURE 
General aspects: 
Preterm birth occurs in 6-15 % of all deliveries. It is the most common 
cause of fetal and neonatal mortality & morbidity. Preterm birth rate increases 
every year. The incidence of perinatal mortality rate in INDIA varies from 40-
150/1000 livebirths. Adverse outcome of preterm birth include cerebral palsy, 
developmental delay, chronic lung disease and visual and hearing loss. 
             40 % of preterm birth due to idiopathic preterm labor, 35% due to 
preterm prelabor rupture of membranes and remainder are iatrogenic, because of 
obstetrics and medical condition. 
Definition and incidence: 
            Preterm birth is estimated to affect 13 million birth/per annum 
worldwide. It is defined by WHO as the onset of labor after the viability and 
before 37 completed weeks or 259 days of pregnancy. 
          The onset of labor determined by documented uterine contractions atleast 
one in 10 min and ruptured membranes or documented cervical changes like 
cervical length of less than 1cm or cervical dilatation of more than 2 
cm.Threatenedpreterm labor is defined by documented uterine contractions but 
no evidence of cervical changes. 
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            The incidence of preterm birth vary widely ranging from 4.4  to 12.7%. 
The  current estimation  of preterm delivery is increasing, compared to previous 
year, because of increased survival of extremely preterm and very low birth 
weight infants.50% PTD are spontaneous preterm labour,30% all due to preterm 
premature rupture of membranes and remaining 20% are indicated preterm 
delivery for maternal & fetal indication1. 
            The increasing incidence of spontaneous preterm delivery is due to 
multiple birth secondary to assisted reproductive techniques, increasing body 
mass index, and sexually transmitted diseases. preterm labor accounts for 
70%neonatal mortality and 50% of long term neurological morbidity. 
According to CESDI (confidence enquiry into still births and deaths in infancy 
UK), these are major antecedents of preterm labor. 
1. Major placental bleeding 18% 
2. Pregnancy induced hypertension 21% 
3. Prelabour rupture of membranes 31% 
4. Clinical chorioamnionitis 11% 
5. Idiopathic preterm labor 55% 
6. Cervical incompetence 5% 
7. Bacteriuria 7%  
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 Because of this diverse etiology, we should have a diversity of management 
regimens towards improving neonatal outcomes by trying to prevent delivery 
before 34 weeks or delaying delivery to optimize the available resources prior to 
delivery. 
Before applying the management regimens we must be aware of the 
efficiency & inherent risks to mother and baby. 
THRESHOLD OF VIABILITY: 
The current threshold of viability of a fetus is 26 weeks(ACOG 
2002,2008 c). Birth  before 26 weeks or birth weight less than 750 g pose a 
variety of complex medical social & ethical consideration. 
According to American academy of pediatrics(branner and co.2000) 
resuscitation for infants less than 23 weeks or birth weight less than 400 gm is 
not appropriate. 
They are more vulnerable for brain injury, like hypoxic ischemic injury 
and sepsis.(stoil& associates). Sepsis and hypoxia start a cascade  of events 
which lead to white matter injury& periventricular leukomalacia and later 
neurodevelopmental impairment. Active brain development occur in second and 
third trimester. Infants born at 22-25 weeks are more vulnerable to brain injury 
because of preterm immaturity. Those with birthweights 500-750 g, 55% 
survived, most of them had complications. Some infants apparently normal at 
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the time of discharge,but affected by serious developmental impairment by age 
8 to 9 years. 
Survival increased from 1.7% at 22 weeks to 54% at 25 weeks. Infants 
born at 22-25 weeks had neurological disability in 25% compared with normal 
term births. Cognitive scores were lower for infants born at 22-25 weeks 
 The infants born at 22-25 wks were analysed ,they were undergoing 
neurodevelopmental testing  at 18-22 weeks of age (Tyson and associate 
2008).61% died or had profound impairment. Female gender, singleton 
pregnancy, corticosteroid given for lung maturation and higher gestational age 
improved the prognosis in these infants born at the threshold of viability. 
caesarean delivery is controversial to the threshold of viability.it was not 
associated with a reduction in the short term serious morbidities(Louis and 
colleagues 2004). 
Late preterm birth 
It accounts for 75% of all preterm births. Infant born between 34-36 
weeks were considered as late preterm births2. 80% of late preterm births were 
due to idiopathic spontaneous preterm labor or prematurely ruptured 
membranes.another 20% due to complications such as hypertension, placental 
accidents and IUGR(Mcintire and leveno 2008). Neonatal mortality and 
morbidity was significantly increased in late preterm infants(tomashek and 
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coworkers 2007).Neurodevelopment was adversely affected in late preterm 
infants(petrini and coworkers 2009). So healthcare focus on prematurity should 
be expanded to late preterm births also2. The late preterm deliveries should 
occur only when there is an accepted maternal and fetal indications                    
(ACOG 2008). 
High risk factor for preterms 
In History 
 Previous history of abortions (spontaneous/induced)  
 Previous history of preterm delivery 
 Pregnancy followed by artificial reproductive technology 
 Recurrent UTI/Asymptomatic bacteriuria 
 Smoking,low socioeconomic  and nutritional status  
 Maternal stress 
In present pregnancy 
MATERNAL 
Pregnancy complications 
 Preeclampsia 
 Antipartum hemaorrhage 
 Preterm premature rupture of membranes 
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 Polyhydramnios 
UTERINE ANOMALIES                 
 Cervical incompetence  
 Malformations of uterus 
MEDICAL AND SURGICAL ILLNESS 
 Acute fever  
 Acute pyelonephritis  
 Diarrhea 
 Acute appendicitis 
 Toxoplasmosis 
CHRONIC DISEASE 
 Hypertension 
 Nephritis 
 Diabetes mellitus 
 Severe anemia 
 Decompensated heart disease 
GENITAL TRACT INFECTIONS 
 Bacterial vaginosis 
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 Beta hemolytic streptococcus infection 
 Chlamydial infection 
 Mycoplasma 
FETAL 
 Multiple pregnancy 
 Congenital malformations  
 Intrauterine death 
PLACENTA 
 Infarction  
 Thrombosis 
 Placenta Previa 
 Abruptio Placentae 
IATROGENIC –due to medical and obstetric complications 
IDIOPATHIC- 50% cause of preterm births are not known. Premature 
activation of some systems involved in initiation of labor at term 
Etiopathogenesis: 
1. Activation of fetal HPA axis. 
2. Choriodecidual bacterial colonization1 
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 Increased TNF, increased IL 1,6,8 
3.Pathological uterine enlargement 
 Increased mechanical stretch, increased IL 8 
 Increased Gap junction, increased PG synthesis. 
 
                   CHORION /AMNION/ AND DECIDUA 
 
 Increased PGE 2,F2 alpha, increased TxA2 
 Increased prostaglandin dehydrogenase 
 Increased collagenase 
 ↑Leukocyte elastase 
 
 
 ↑myometrial contraction 
 
 ↑cervical ripening 
 
 
 ↑cervical insufficiency 
 
Leads to  
Preterm labor and preterm delivery 
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ANTECEDANTS AND CONTRIBUTING FACTORS: 
1.THREATENED ABORTION: 
First trimester  vaginal  bleeding  were  associated  with 
subsequent preterm labor ,placental  abruption  and subsequent  
pregnancy loss  less than 24 weeks(Weiss and associates 2004) 
2.LIFE STYLE FACTORS: 
 Cigarette smoking 
 Inadequate maternal weight gain 
 Illicit drug use 
 Overweight women(Ehrenberg and colleagues 2009) 
Specially prenatal weightgain is associated with preterm  
labor(hickey and colleagues 1995) 
 Young and advanced maternal age 
 Poverty 
 Short stature 
 Vitamin deficiency 
 Prolonged walking or standing 
 Strenuous work 
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 Psychological factors like depression, anxiety and chronic 
stress(merces 2002 and their associates)(neggers and coworkers 
2004) 
3. RACIAL AND ETHINIC DISPARITY: 
Compared to white, blacks are more prone to preterm 
birth(Goldenberg and colleagues 2008b) especially recurrent preterm 
delivery Other association include low socio economic status and 
educational status(Kistka and colleagues2007) 
4.GENETIC FACTORS: 
The recurrent and familial nature of the preterm birth has led to 
that genetics may play a role. Involvement of immunoregulatory 
genes in potentiating chorioamnionitis in case of  preterm delivery 
was analysed in various study(Gihson 2007, Hampton 2006) 
5.PERIODANTAL DISEASE: 
Gum infection was significantly associated with preterm birth 
(Goepfert and coworkers 2004). But studies found that treatment of 
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periodontal disease during pregnancy did not significantly alter the 
rates of preterm birth. 
6. INTERVAL BETWEEN PREGNANCIES: 
Short interval less than 18months and longer than 59 months 
between pregnancy were associated with increased risk of  
pretermbirth (Conde-Agudelo and coworkers 2006) 
7.PRIOR PRETERM BIRTH: 
Prior preterm deliveries one of the main risk factor.(Bloom and 
associates 2001). The risk was increased 3 fold following one preterm 
delivery. Incidence was 5-15% following one preterm delivery and 
increased to 41% following two preterm delivery. But this may 
contribute to only 10% of preterm delivery. So 90% of preterm births 
cannot be predicted with the history of previous preterm births. 
8.INFECTION: 
Intrauterine infection trigger the preterm labour. Inflammatory 
cytokines released by the microorganisms stimulate the production of 
prostaglandins and matrix degrading enzymes. Interluekins and TNF 
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were involved in this process. These prostaglandins stimulate the 
uterine contractions. Preterm rupture of membranes occur due to 
degradation of extracellular matrix in the fetal membranes. Incidence 
of intrauterine infections in preterm labor was 25-40%.The two 
microorganisms involved in preterm labor were ureaplasma 
urealyticum and mycoplasmahominis(Goldenberg and colleagues 
2008a).Short cervix was associated with microbial invasion due to the 
ascent from the genital tract. Antimicrobial treatment was tried to 
reduce the rate of preterm labour. But it did not reduce the rate of 
preterm birth or chorioamnionitis (histological).(Tita and coworkers 
2007 )  
Bacterial vaginosis: 
The lactobacillus predominant vaginal flora replaced by 
anaerobes like gardenellavaginalis, mobiluncus& mycoplasma 
hominis. 
             It is associated with spontaneous abortion, preterm rupture of 
membrane, preterm labour and chrioamnionitis(hillier 1995, leitich 
2003a). women with bacterial vaginosis and susceptible TNF alpha 
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genotype  had 9 fold increased risk of preterm birth(macones and  
colleagues 2004) 
     But screening and treatment of bacterial vaginosis did not prevent 
preterm birth (okun and associates 2005) 
RISK OF PRETERM BIRTHS 
MATERNAL RISK 
 GENERAL RISK: 
Most common maternal complication is postpartum endometritis 
but it responds rapidly to antibiotics 
RISK DUE TO TOCOLYTIC AGENTS: 
     Beta sympathomimetics were associated with adverse maternal 
effect like chest pain(10%), dyspnea, tachycardia, palpitation(48%), 
tremor (39%), hypokalemia, hyperglycemia, nausea(20%) and 
headache(21%)(Cochrane review, gyetvai and colleagues) Pulmonary 
edema is life threatening adverse effect. It is more common in 
multiple gestation and who receiving corticosteroid for lung maturity. 
Other contributory factor was combination of tocolytic agents 
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unrecognized chrioamnionitis and fluid overload. An infrequent but 
serious maternal complication is myocardial ischemia due to 
myocardial micronecrosis. 
Non steroidal antiinflammatory inhibits cox enzymes. Which plays 
main role in the initiation and maintenance of labor . Side effect of 
NSAID were peptic ulcer, GI bleed, PPH, renal failure and 
thrombocytopenia. Comparison of non selective COX inhibitors 
versus COX2 inhibitor did not show any difference in maternal side 
effects(king and associates) 
               Calcium channel blockers produce pulmonary edema, 
maternal hypotension& hepatotoxicity. caution is advised if 
magnesium sulphate is used concurrently because of potentiation of 
the side effect.( king and associates) 
FETAL RISK: 
The effect of preterm birth on the fetus depending on the gestational 
age at the time of birth and birth weight. Prematurity is classified into 
three groups 
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 Severe prematurity < 30 wks 
 Intermediate prematurity 30-34 weeks 
 Late or mild prematurity 34-37 weeks 
All obstetrical resources should be used to avoid severe and 
intermediate permaturity. These births should occur in tertiary 
center with adequate neonatal intensive care facilities. Mild 
prematurity can be managed in level 2 nurseries(hagen et al 1993) 
CONSEQUENCES IN FETUS: 
 Neonatal Respiratory Distress Syndrome  
 Intraventricular haemorrhage 
 Bronchopulmonary Dysplasia 
 Necrotising enterocolitis 
 Cerebral palsy 
These complication are common before 28 weeks and extends in to 
30-32 weeks(mol et al 1999) 
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SCREENING METHODS 
The symptoms and signs of preterm labor vary only a little from 
the normal physiololgical symptoms and signs of pregnancy, so early 
detection of preterm labor or preterm rupture of membranes in routine 
antenatal care is often problematic. The diagnostic criteria for preterm 
labor is defined by the onset of frequent uterine contractions with 
progressive effacement and dilatation of cervix. It can be assessed 
once the uterine contractions occur every 10 mins and 80%  of  
cervical effacement & 3 cm cervical dilatation. But most of the 
patients present with mild symptoms and signs of labor. When the 
thresholds for contraction and cervical changes lowers, it will affect 
the sensitivity and positive predictive value for detection of preterm 
labor. 
The screening test, which predicts the preterm birth would have 
high sensitivity and high negative predictive value. The available 
screening tools did not decrease the incidence of preterm birth. Now 
wide variety of screening tools have been evaluated in 
research.(fonseca and associates 2007). 
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MONITORING UTERINE ACTIVITY: 
Simplest method to monitor the uterine activity is to teach the 
patient about the uterine contractions and how to palpate and record 
her own contraction. Patient should monitor the  contraction for 1 
hour twice a day3. This technique is easy and non expensive, but it is 
completely subjective and  known to have poor sensitivity. It will also 
increase the patient anxiety which in turn increase the risk of preterm 
labor. 
Another method of monitoring is tocography monitoring. 
Several studies showed that preterm delivery rate was reduced in the 
monitored group, but sensitivity and specificity of tocometer vary.                  
It depend on the tension of the belt  and the thickness of the maternal 
abdominal wall. It is also expensive and time consuming. So it is not 
suitable for low risk mother,but better for high risk mother. 
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CERVIACAL SCREENING: 
  Normally the cervical effacement starts at 32 weeks of 
pregnancy.  This process begins in 16-24 weeks in patients affected 
by preterm labor. This effacement usually begins at the internal os. It 
can be seen as cervical shortening and cervical funneling. It can be 
detected by trans vaginal USG. 
          USG assessment of cervix is used to improve the accuracy of  
the diagnosis of preterm labor and to predict the women who enter in 
to preterm labor. 
     Several studies shows assessment of cervical length& 
funneling either alone or in combination is useful in predicting 
spontaneous preterm labor in asymptomatic women. 
DIGITAL MEASUREMENT OF THE CERVIX: 
   Studies show that digital assessment of the cervix is highly 
subjective. It does not correlate with transvaginal assessment. 
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USG MAESUREMENT OF CERVIX: 
       Cervix is measured by ULTRASONOGRAM  by 3 routes4 
 Trans abdominal 
 Trans vaginal  
 Trans perineal 
Cervix is a dynamic structure. Cervical measurements are affected 
by abdominal pressure and bladder filling. 
 After emptying the bladder a transvaginal probe is introduced in to 
the anterior fornix of the vagina. Avoid undue pressure on the cervix. 
It will distort the anatomy. In sagittal section the whole length of the 
endocervical mucosa is identified. The distance between external os 
to internal os is measured. Minimum 3 measurements are made and 
the shortest length is reported4. 
Transabdominal and transperineal assessment is used, in the 
situation in which vaginal examination ideally would be avoided like 
pre term prelabor rupture of membrane. In trans abdominal route the 
shortening of cervix is identified in 13 % of the cases. If the bladder is 
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full it is easy to access the length of the cervix but it may be 
associated with the increase in length of the cervix. 
          In sagittal section, the curvature of the endocervical canal affect 
the measurement .So there would be a potential for false positive 
reports. 
Cervical funneling is an independent predictive value for 
preterm delivery. It can be measured by dilatation of the internal os 
and endo cervical canal length. Combination of these factors gives a 
cervical index. Funneling was defined as if the  width at the internal 
cervical os greater than 5 mm. 
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CERVICAL ASSESSMENT IN HIGH RISK ASYMPTOMATIC 
PATIENT: 
       HIGH RISK MOTHER:  
 Previous Preterm Labor 
 History of Previous Preterm Prelabor Rupture Of Membranes 
 Previous Cervical Surgery 
 Uterine Anomaly 
In high risk patients there is a strong association between short 
cervix and preterm labor6. 
           Several studies showed that a single examination at 16-19 
weeks of gestation with cervical length of 25 mm or less is associated 
with increased risk of preterm labor at 35 weeks. The negative 
predictive value of this cutter is 96 %. If cervical examination was 
done up to 24 weeks a single measurement of less than 25 mm is 
associated with preterm delivery about 4.2 times. 
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CERVICAL ASSESSMENT IN LOW RISK ASYMPTOMATIC 
PATIENT: 
              Significant preterm deliveries occur in low risk population 
with no historical risk factor.(Iams and coworkers) Studies shows 
evaluation of cervical length seems to be similar predictive value in 
low risk patient also. Till recently scanning in low risk patient was not 
useful, because the effective intervention to improve pregnancy 
outcome was not documented. 
             One randomized trail shows, screening the cervical length 
between 20-25 weeks& effective intervention for those with cervical 
length of less than 15 mm with progesterone up to 34 weeks will 
reduce the risk of preterm labor. But it did not show reduction of 
perinatal mortality and morbidity(Fonseca and associates 2007) 
              Final conclusion is the screening test like, transvaginal 
assessment of length of cervix should be offered to all women5. It 
should be done at the time of routine anomaly scan. It can identify 
high risk women who need close monitoring & corticosteroid need. 
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CERVICAL ASSESSMENT IN SYMPTOMATIC PRETERM LABOR: 
                 Early diagnosis of preterm labor is essential to reduce the 
risk of preterm labor or to optimize the condition for premature 
neonate. The cervical assessment by digital examination is important. 
But it has interobserver error. The USG assessment is essential in 
symptomatic women, for earlier treatment of the patient with cervical 
changes and also reducing the unnecessary treatment for patient who 
are not in preterm labor6. 
CERVICAL SCREENING IN TWIN PREGNANCY: 
  Approximately 5-10% of twins deliver before 33 weeks of 
gestation. The preterm delivery is increased to 6 fold in multiple 
gestation. Several studies show insufficient data about cervical length 
in twin pregnancy to predict preterm delivery. 
INCOMPETENT CERVIX: 
          Cervical incompetence is a clinical diagnosis. It is recurrent 
painless cervical dilatation and spontaneous mid trimester birth in the 
absence of spontaneous rupture, bleeding and infection. 
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CERVICOVAGINAL FETAL FIBRONECTIN: 
          It is a glycoprotein. It is found in decidua, placenta and 
amniotic fluid. It is important for implantation and placental and 
uterine attachment.(Leeron and colleagues 1996). It is found in 
cervical screening in 16-18 weeks of gestation because in early weeks 
the fusion of fetal membranes and decidua is incomplete. Again the 
fibronectin is found at the time of onset of labor. In between 22- 37 
weeks it is not found in cervical screening12. If chronic decidual 
disruption occur due to infection in 2 nd and early part of 3 rd 
trimester (lockwood and co workers 1991)it will leak into the cervical 
secretion. 
            ELISA assay has been developed as bed side test to detect 
total fibronectin. Digital examination , sexual intercourse, PPROM, 
and vaginal bleeding affect the test result.so it produces false positive 
results. It has a sensitivity of 53% and specificity of 89% value more 
than 50 ng/ml is positive. Negative result associated with fewer 
admission and decreased hospital stay13.(love and asoociates). 
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            The combination of ultrasound assessment of cervical length 
and fibronectin had better prediction of  preterm labor21(Rizzo and co 
workers). Several studies show that fetal fibronectin assessment after 
cervical length assessment was more specific21( Schmitz and 
associates) 
SCREENING FOR BACTERIAL VAGINOSIS ; 
  Bacterial vaginosis is an over growth of mixture of many 
microbes-Like Gardenellavaginalis, mobiluncus and mycoplasma 
hominis. Its role in preterm labor is poorly described. But the risk is 
double with bacterial vaginosis. Early pregnancy infection  greater 
risk than late pregnancy infection.( Leitich and co workers). 
Screening and subsequent treatment of bacterial vaginosis remains 
controversial16. Treatment of bacterial vaginosis with antibiotics did 
not reduce the risk of preterm birth.(Cochrane collaboration). But it 
reduce risk of PPROM  screening and treatment of bacterial vaginosis 
has benefit only in high risk women, but more studies are required. 
 
31 
 
RECOMMENDED SCREENING STRATEGIES TO PREVENT 
PRETERM BIRTH(ACOG 2001,2008 A)  
 Screening For Preterm Labor In Low Risk Population Is Not 
Beneficial 
 Currentdata Not Supporting The Home Uterine Activity 
Monitoring And Bacterial Vaginosis Screening. 
 Cervical Length Assessment And Fetal Fibronectin May Be 
Useful, But Only their Negative Predictive Value Is Valuable. 
INSULIN LIKE GROWTH FACTOR BINDING PROTEIN-I  
   INSULIN LIKE GROWTH FACTOR BINDING PROTEIN-I is 
one of the major protein, found in human decidua & amniotic fluid. 
Its concentration is 10-100 times higher in amniotic fluid than 
serum17. Amniotic fluid contains non phosphorylated forms, decidua 
contains phosphorylated form. 
INSULIN LIKE GROWTH FACTOR system contains INSULIN 
LIKE GROWTH FACTOR-I and INSULIN LIKE GROWTH FACTOR-
II receptors and binding protein. It has a control mechanism in fetal 
and placental growth and development. 
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INSULIN LIKE GROWTH FACTOR BINDING PROTEIN was 
formerly known as placental protein-II. It was isolated 15years ago, 
radio immune assay was developed measuring both is form of 
phIGFBP-1           
In PPROM and preterm labor, INSULIN LIKE GROWTH 
FACTOR BINDING PROTEIN-I found in cervical secretions, 
commercial strip is available to detect it presence. 
Its Sensitivity iwas94- 96%, specificity is 95%, but in clinical 
application 74% sensitivity has been documented.(kekki et al). It has 
high negative predictive value 92%,its positive predictive value was  
63%. Its concentration I of at least 10 micro gram/liter in Cervical 
swab indicates 10 fold increase   the risk of preterm delivery18                   
kekki et al). 
             Some studies compare the value of cervical phIGFBP-1 with 
cervical length measurement20. The cervical length at 22-24 weeks 
and INSULIN LIKE GROWTH FACTOR BINDING PROTEIN-I 
measurement were useful to detect preterm delivery.(bitter et al) 
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Many other protein like , FFN , IL 119 ,IL 8 and TNF alpha also 
be evaluated as biochemical predictor for threatened preterm delivery. 
FFN produced by chorion. It is detected by monoclonal antibody FDC 
6. FFN is cervical secretion test vary in their sensitivity, specificity 
and their predictive value in different studies. Because of the 
multifactorial etiology of preterm birth its prediction never become 
100 % so combination of markers may help to come to diagnosis very 
closely. 
  Infection can activate the cytokine pathway. It trigger the 
production of extracellular matrix degradation proteases in decidua 
and fetal  membrane, it also increases prostaglandin production.It 
leads to uterine contraction and cervical changes. It also releases the 
chorionic or decidual proteins from the interface of decidua and 
chorion, so decidual isoform IGFBP 1 also released in cervico vaginal 
secretion17. In contrast to FFN only small amount of IGFBP 1 is 
present in urine and seminal plasma. So recent intercourse does not 
affect the test results. But preterm premature rupture of membranes 
gives false positive result. 
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OTHER PREDICTORS OF PRETERM LABOUR20:  
 Placental Corticotropin Releasing Hormone And Its 
Hinding Protein 
 Salivary Estriol 
 Inflammatory Cytokines And Prostaglandins 
 Cervical Ferritin 
 Non Invasive Cutaneous Cardiovascular Dynamics 
But these markers are not reliable marker of preterm labour23. 
PREVENTION OF PRETERM LABOR 
PER PREGNANCY PREVENTIVE MEAUSRES: 
Pre pregnancy counseling regarding recurrence of preterm 
delivery, because previous preterm birth is most significant risk 
factor.(ashamed and colleagues). One previous preterm delivery had 
15% recurrence and 2 previous preterm delivery had 41% recurrence. 
Counsel the women living remote from a perinatal center and suggest 
relocating during the critical period. Advice regarding avoidance of 
heavy manual labor, mental stress, smoking , alcohol, and chemical 
dependency. 
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PRENATAL PREVENTION: 
1) ASSESSMENT OF RISK: 
Risk assessment done by proper history taking and clinical 
examination. Scoring system (creasy and anouales) which uses socio 
economic factor, medical history and habit of women was tried, but 
Scoring system predictive value is low(17- 34%) 
2) EDUCATION OF PATIENT: 
Patient education about signs and symptoms of preterm labor is 
useful. Some signs and symptoms of preterm labor were menstrual 
like cramps, pelvic pressure sensation, dull head ache, perception of 
contraction and a show. If these symptoms are present a through 
cervical assessment by USG is essential. 
ANTENATAL CARE: 
If patient is high risk for preterm labor the antenatal assessment 
need to be more frequent in the second trimester because, early and 
frequent antenatal care can detect some of the maternal and fetal 
conditions like anemia, GHT, asymptomatic bacteuria (Bowes and 
associates) 
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PRIMARY PREVENTIVE STRATEGIES OF PRETERM 
LABOUR: 
PROGESTERONE: 
According to csapo 1956,progesterone maintain the uterine 
quiescence and block the labour initiation.A study conducted by 
NICHD Maternal Fetal Medicine units network at 2003,they used 
injection 17-hydroxy progesterone caproate weekly from 16 weeks to 
36 weeks15. The rate of preterm delivery was reduced significantly. 
But the study conducted by carities and associates 2009 shows no 
improvement with progesterone. Progesterone vaginal suppositories 
200mg were associated with decrease in preterm birth before 34 
weeks(fonseca and collegues 2003,2007) It also reduce preterm 
delivery in patients with short cervix. According to ACOG 2008, 
progesterone therapy should be limited to women who had previous 
preterm birth. But further studies are needed. 
CERVICAL ENCIRCLAGE 
The early second trimester USG can identify the asymptomatic 
cervical changes like shortening of length and funneling of cervix. 
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According to RCOG trial,the Mc Donald suture significantly reduces 
the preterm birth before 33 weeks but there was no improvement in 
preterm birth before 37 weeks , still birth, and neonatal death. 1 out of 
30 will be benefited by cervical encirclage6. Cerclage had limited risk 
in low and moderate risk of preterm delivery. (Cochrane review by 
drakely and co workers) 
3 indications of cervical encerclage: 
1. Previous history of recurrent 2nd trimester losses and diagnosed 
as cervical incompetence 
2. Short cervix which was identified byUSG 
3. Rescue cerclage- done as an emergency procedure 
TREATMENT FOR VAGINAL INFECTION 
Currently there is insufficient evidence available for 
prophylactic antibiotics during pregnancy to prevent preterm delivery 
( Cochrane review by Othman and associates) 
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Principles of management of preterm labour: 
 Glucocorticoids 
 Bed rest 
 Hydration and sedation 
 Antenatal transfer 
 Tocolytic agents- in appropriate situations 
 Antibiotics- if needed 
 Careful intrapartum monitoring 
 Route of delivery 
Bed Rest: 
According to some studies, they concluded that the available 
evidence neither supported nor refused the use of bedrest in preterm 
labour (Cochrane database sosa and associates 2004) 
Corticosteroids: 
Corticosteroids accelerate the lung maturation of fetus.Its lowers 
the incidence of respiratory distress syndrome and neonatal mortality 
rates (liggins and Howie 1972). Dexamethasone given as 6mg im 
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every 12hrly for 48 hrs.Betamethasone given as 12 mg every 24hrs 
for 2 doses. 
Antenatalcorticosteroids reduce the neonatal death due to 
respiratory distress syndrome with respiration support14 and decreases 
the neonatal intensive care admission and neonatal 
cerebroventricularhemorrhage (Roberts and Dalziel). But no 
demonstrated increased risk to the mother as chorioamnioitis or 
puerperal sepsis. Some clinicians administered steroids  at weekly 
interval. But some trials show 4 or more courses of steroids7 increase 
the incidence of cerebral palsy or neonatal death (NICHD trial of 
Wagner and Australasian collaborative trial of repeat doses of 
steroids). Behavioral problems like ADHD, emotional reactivity is 
increased in repeated course group. ( crowther and colleagues). In 
some studies, the neonatal growth parameters was reduced due to 
repeated courses of steroids ( Murphy and associates- MACS- 
multiple courses and antenatal corticosteroids for preterm birth trial). 
According to ACOG and NIH (national Institute of Health) , one 
course of betamethasone (12 mg, 2 doses, 24 hoursapart) should be 
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given in preterm labour. Rescue dose is not allowed. Many 
investigation are under way regarding the use of different types of 
corticosteroids. According to Mittendorf and co workers, if high 
exposure to Magnesium in Preterm labour occurs, betamethasone may 
be less effective to prevent intra ventricular hemorrhage.  
RCOG Guidelines 
It would be indicated in all women who is in high risk of 
preterm labour in between 24-34 weeks. If there is pulmonary 
immaturity it should be given in  more than 34 weeks. 
It should be given still after 37 weeks in neonates born by 
elective cesarean. It significantly reduces RDS and transient 
tachypnea of newborn. Corticosteroid therapy should be started 
immediately in high risk women, unless delivery is imminent. 
Betamethasone is the steroid of choice because it reduces the 
risk of deathof neonates than dexamethasone and also reduces the risk 
of periventricular leucomalacia( Lee study) Antenatal corticosteroids 
is contraindicated in maternal systemic infections like tuberculosis. In 
chorioamnionitis, caution is recommended. In GDM patients close 
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monitoring is essential in the first 3 days to avoid transient 
hyperglycemia. Usually, steroid effect begins after 12 hours of first 
dose and it lasts for 5 days. 
TOCOLYTICS 
1.β ADRENERGIC AGONISTS 
It reduces intracellular calcium level and prevents myometrial 
contractile protein activation. 
 Ritodrine8  
It resulted in serious maternal and fetal side effects.Tocolysis is 
third most common cause of acute respiratory distress and death in 
pregnant woman because of pulmonary edema. Because beta agonist 
cause water and sodium retention that leads to volume 
overload.(Hankins and colleagues 1988).It is not used nowadays. 
 Terbutaline: 
Continuous use of terbutaline is not advised. It also causes 
pulmonary edema,sudden maternal death and neonatal myocardial 
necrosis(fletcher and colleagues).Oral therapy is also not effective 
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 Calcium channel blockers: 
It inhibits calcium channels in the cell membrane thereby reducing 
the myometrial activity10.Nifedipine is the most commonly used since 
it safe and more effective than beta agonist (king and colleagues 
2003).Nifedipine is given as 20 -30 mg STAT followed by 10-20 mg 
tds for 48hrs.It will not prolong the pregnancy when used 
concurrently with MgSO4. The combination is most dangerous 
because Nifedipine enhances the neuromuscular blocking effects of 
magnesium9.  Thus it interferes with cardiac and pulmonary 
function(Kurtzman and associates). 
 Prostaglandin Inhibitor: 
Prostaglandin synthase is involved in conversion of arachidonic 
acid to prostaglandin.Because prostaglandins are involved in the 
mechanism of labor. The drugs that block the prostaglandin 
production like acetyl salicylate and indomethacin were used to 
prevent preterm labour(Zukerman and associates 1974).It can be 
given 50-100 mg at 8hrs interval. Not to exceed 200 mg in 24hrs 
interval.But it produces oligohydraminos and it will be reversible. 
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Several studies show that it will produce neonatal necrotizing 
enterocolitis(Muench and coworkers 2001). 
 MgSO4: 
High concentration of ionic magnesium decreases the 
myometrial activity.It is a calcium antagonist.But close monitoring of 
magnesium sulphate toxicity is essential(samol and lambers 2005). 
MgSO4 produces neuroprotective effectin neonates especially in 
24-28 weeks11.Because it stabilizes the intracranial tissue,decreases 
the fluctuation in cerebral blood flow ,reduces the synthesis of 
cytokines and bacterial endotoxins and decreases the effect of 
inflammation(Nelson Aslanyan And colleauges 2007,crowther and 
colleagues 2003 Rouse and colleagues 2008). 
 Atosiban: 
It is a oxytocin antagonist .But in Randomized clinicaltrails, 
shows it improves neonatal outcome and also it was associated with 
neonatal morbidity. (moutquis&co workers 2000) 
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1.Nitrous oxide donors: 
It is smooth muscle relaxant, but it was not effective than other 
tocolytics. Maternal hypotension is common side effects. 
These tocolytics are used to stop preterm labor temporarily. But it 
doesnot prevent preterm labor. It is used for antenatal corticosteroid 
therapy & antenatal transfer of patients to tertiary care hospital where 
the NICU facilities are available. It does not improve neonatal 
outcome (berkman and associates 2003) 
ANTIBIOTICS: 
  Antibiotics use in preterm labor does not improve the neonatal 
outcome(ORACLE II trail).  This study shows increased cerebral 
palsy rate in treated groups. The mechanism is, sub clinical infection 
must provoke labor was suppressed with antibiotics, but not 
eliminated. It will cause continues exposure of fetus to toxic 
environment & perinatal infection and neurological impairment. But 
overt infection should be treated with antibiotics. 
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MANAGEMENT OF WOMEN WITH THREATENED OR 
ESTABLISHED PRETERM LABOR: 
 Once preterm diagnosis is made, start the clinical appraisal and 
appropriate investigation about the maternal and fetal condition. USG 
is used to assess the fetal weight, fetal biometry, presentation and 
liquor volume, placental site, and cervical length. Doppler 
asscessment for fetal well being.Vaginal and urine culture & 
sensitivity to ruleout  infective etiology.Complete blood count. and                  
C reactive protein also important. Amniocentesis is used for fetal lung 
maturity assessment, gram stain and culture. IL 6 estimation may be 
considered. 
                 The outcome was poor in 20-24 weeks, it will be discussed 
with before starting tocolytics. in this situation parents should be 
allowed to choose the options regarding delivery . In 24 – 34 weeks 
give corticosteroids and tocolytics , it will facilitate inutero transfer of 
fetus to tertiary care level and fetal lung maturity. Calcium channel 
blocker is the first line tocolytics because of cheaper cost , easy 
administration and fewer maternal side effects than beta 
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sympathomimmetics23. It should be continued for 48 hours. Use of 
tocolytics more than 48 hours doesnot prevent preterm delivery. If it 
is not tolerable, alternative agent should be used. Intrauterine 
infection is the main cause of tocolysis failure, so it should be used 
with caution.  Give antibiotics if there is overt maternal infection. 
Emergency cerclage is limited value. 
LABOR AND DELIVERY: 
If Preterm delivery is inevitable , the mode of delivery will be 
discussed with the parents by multidisciplinary team. Before 24 
weeks vaginal delivery should be anticipated. In 24 – 34 weeks the 
management of labor not differ from beyond 34 weeks. If there is 
signs of intrauterine infection, antibiotic therapy should be started to 
prevent maternal morbidity. Group b streptococcal infections are also 
dangerous to preterm neonates. Prophylactic outlet forceps and 
episiotomy doesnot improve the neonatal outcome. They should be 
used only in obstetric indication. Vacuum delivery is contraindicated 
before 34 weeks. 
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In extreme preterm { 24- 28 weeks} EN CAUL method of delivery is 
associated with higher cord ph because intact amniotic membrane 
helps to product the fetus from mechanical forces during vaginal 
birth. The delivery should be done in tertiary level care where 
neonatologist and neonatal intensive care facility  is available.      
PRINCIPLE OF MANAGEMENT IN PRETERM LABOR: 
1. FIRST STAGE OF LABOR: 
 Bed rest – to avoid early rupture of membrane 
 Adequate fetal oxygenation 
 Epidual analgesia 
 Labor should be carefully monitored with continuous electronic 
fetal monitoring 
 Caesarean delivery- for obstetric indication only 
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SECOND STAGE OF LABOR 
The birth should be gentle and slow to  avoid rapid compression and 
decompression of the head 
 Episiotomy 
 Cord should be clamped immediately after birth to avoid 
hypervolemia and hyperbilirubinemia 
 Shift the neonates to the intensive care unit under the care of 
neonatologist 
POST NATAL MANAGEMENT 
MOTHER: 
 Encouragement of parent and infant bonding  
 Breast feeding should be encouraged  
 Continues psychological support to the mother is important 
NEONATE: 
                Premature neonates should adopt the extra uterine life 
because the different organ system undergo continues functional and 
structural development and maturation ( lee and colleagues). Lung 
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immaturity is the major cause of respiratory distress syndrome, and 
poorly developed respiratory control may lead to recurrent apnea. Due 
to patent ductus arteriosus, congestive cardiac failure may occur. 
Liver immaturity is likely to be associated with severe neonatal 
jaundice(morris and Tyson). 
 In extremely premature infants chronic lung disease and 
retinopathy are long term complication. In hypoxic ischemic 
encephalopathy, head cooling method is used to improve the 
neurological morbidity of preterm neonates ( Jacobs and associates). 
Maturity  of lung is the main factor in determining the prognosis of 
preterm infants. 
Minimizing the severity and incidence of respiratory distress 
syndrome is the major factor for the improvement of neonatal 
mortality and morbidity. Perinatal care, selective use of tocolytics and 
maternal corticosteriod administration all are enhance the lung 
maturity. Prophylactic use of exogenous surfactant & rescue use of 
surfactant in mechanically ventilated neonates are reduce the 
respiratory morbidity. 
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1.MINNAMAIJA KEKKIAND ASSOCIATES (2001) 
IGFBP-1 in cervical secretion as a predictor of preterm delivery 
This is a prospective study analyzing 63 women with PTL. Aim 
of this study was to identify the accuracy of phosphorylated isoform 
of IGFBP-1 in cervical secretion in symptomatic women with intact 
membrane in predicting increased risk of PTD.  
7 of 17 (41%) positive women delivered as preterm before 35 
weeks.3 0f 46 (7%) negative women delivered as preterm before 37 
weeks .In control population, 3 out of 58(5%) women had positive 
results, but none of these women delivered as preterm 
In this study the median number of weeks between the first 
presentation with preterm contraction to delivery was 10.2 in negative 
group and 5.1 in positive group. 
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2.DERYA EROGLU & ASSOCIATES (2006) 
Prediction of PTD among women with threatened preterm labour 
Aim of this study was to analyse the predictive value of fetal 
fibronectin and Ph IGF-BP-1 in cervical secretion and transvaginal 
USG measurement of cervical length for preterm delivery less than 
35weeks. 
51 women with 24-35 weeks gestationand preterm pains were 
included in this study. Ph IGFBP- 1 and fetal fibronectin were 
analysed in cervical secretion. Cervical length was measured with 
transvaginal USG. 
Positive predictive value of fetal fibronectin was 50%, Ph 
IGFBP-1 was 58.3% and cervical length< 20 mm- 100%, cervical 
length was <25 mmm- 66.7%. Negative predictive values for 
fibronectin- 91.9%, for Ph IGF-BP-1- 92.3%, cervical length less than 
20 mm-91.1% and cervical length, less than 25mm- 90.5% 
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In this study group, preterm birth rate was 19.6%. When the 
three tests were combined, positive predictive value of each test was 
increased. 
The study shows that Ph IGF-BP-1 and fibronectin are equally 
good in predicting the PTD  
3.DEVLETA BALIC & ASSOCIATES (2008) 
IGFBP- 1 in cervical secretion as a predictor of preterm delivery 
This was a prospective study. It was conducted in a OBG clinic 
at Tulsa. 80 patients between 24-34 weeks gestation were included in 
this study. After taking proper history, all women underwent IGFBP-1 
measurement in cervical secretion using Actimpartus kit. The 
bishop’s score was determined by per vaginal examination. Rates 
were compared by Spearman Rank co-relation kit, standard deviation, 
student’s t test 
8 patients in the study group had positive Ph IGFBP-1 test.                  
6 patients delivered as preterm. The negative predictive value of this 
test was 98.59%.Positive predictive value of this test was 94.43%. 
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Bishop’s score specificity and sensitivity were 83.78% and 50%. 
Bishop’s score positive predictive value was 20%, negative predictive 
value was 95.36%. But there was no correlation between IGFBP-1 
and bishop’s score. 
Conclusion of this study was IGF-BP-1 is <10µg/L (negative test) in 
asymptomatic women, the risk of PTD is low. The IGF-BP-1 test 
could be used as a screening test in asymptomatic women 
4.H.METE TANVIR & ASSOCIATES 
Cervical Ph IGF-BP-1 for the prediction of preterm delivery in 
symptomatic cases with intact membrane 
It is a prospective and observational study. This study evaluate 
the predictive value of IGF-BP-1 test in symptomatic women with 
PTL, at 24-37 weeks gestation, with intact membrane and less than 3 
cms dilatation are included in this study. 
68 cases were included in this study most of the test positive 
cases has high bishop’s score and low gestational age at delivery( 
P=0.001). Sensitivity was 70%, specificity was 74%, positive 
predictive value was 48%, Negative predictive value was 88%.  The 
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test is based on the immunochromatographic qualitative analysis of 
PhIGFBP-1. All cases are evaluated by mother’s demographic 
characteristics and neonatal outcome. 
Conclusion of this study was that the test had high negative predictive 
value to predict PTD less than 34 weeks and within 7 days. It is useful 
to reassure the patient and avoid unnecessary intervention. 
The author also concluded that there was a strong association 
between gestational age at delivery and cervical length in test positive 
Patient. 
5.ANELA LATIFAGIC& ASSOCIATES 
IGFBP-1 in cervical secretion in women with symptoms of preterm 
delivery 
Aim of this study was to evaluate the value of IGFBP-1 in 
cervix in symptomatic preterm pain patients and also correlation of 
this test with bishop’s score. 30 pregnant women were included. All 
of these women were between 24-34 weeks of pregnancy. The 
concentration of IGFBP-1 was estimated by ActimPartus test. The test 
is considered positive is IGFBP-1 concentration was >10 µg/L. 
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Statistical importance was determined at the variation level of 5% and 
1%. 20 patients in the study group had positive test (66.67%) and 15 
women had preterm delivery. 
 Sensitivity and specificity was 80% and 53.33%  
respectively.Positive predictive value was 33.33%  and negative 
predictive value was 80%. 
In Bishop score, the sensitivity was 93.33% and specificity was 
33.33%.Positive and negative predictive values was 58.33% and 
83.33% respectively. 
In the study group correlation between Actimpartus and Bishop 
score was positive (p<0.05).  Bishop score was a better predictive 
value regarding the prediction of Preterm Delivery than Actim Partus 
test. Statistical significance was good (p=0.003). 
In other studies, the comparison of Foetal Fibronectin and                 
IGFBP 1, sensitivity of IGFBP 1 is better (78%)  than Foetal 
Fibronectin(76%).By using this test, we could be able to avoid 
unnecessary intervention and cost of treatment significantly. 
56 
 
 This study’s conclusion was IGFBP 1 in Cervical Secretion can 
be used as a predictor of Preterm Delivery. But Bishop score more 
than 4 is better predictor than IGFBP 1 in symptomatic preterm 
women. 
6. K.KWEK et al(2004)  
Evaluation of a bedside test for phosphorylated insulin like growth factor 
binding protein- in preterm labour 
This study’s objective was to assess the efficacy of bedside kit 
for IGFBP- 1 in the diagnosis of Preterm Labour. It is a prospective 
study. 47 women with 24-34 weeks of gestation were included in the 
study. Corticosteroid and tocolytics were given to all patients. 
 In 47 patients, 29 women had negative test (61.7%) and 18 
women had positive test (38.3%). The positive group had median 
cervical dilation of 1cm (p<0.05). There was no statistical 
significance of these 2 groups. Tocolytic therapy, stay in the labour 
ward and median duration of hospitalization were longer in test 
positive group (p<0.05) (34.5hour, 56 hour, 5 day). 
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In test negative group, 91.7% of the women had preterm 
delivery after seven days of onset of contraction . In positive group 
44.4% women had delayed delivery after seven days. 
 Sensitivity& specificity of bedside test for phIGFBP-1 were 
73.77% and 82.6%. The positive and negative predictive value were 
77.8% and 79.2%. Small sample size was the drawback of this study.                     
Conclusion of this study was, if there is suspected preterm labor 
a negative test could exclude the diagnosis. So it avoid unnecessary 
obstetric intervention like tocolysis and inutero transfer. 
7.LEMBET ET AL 
It was a prospective study .In this study 36 symptomatic patient 
between 20 to 36 weeks gestation was included. 18 patients  had 
positive actimpartus test, other 18 had negative test. Among the 18, 
one delivered at term. 17 patients delivered less than 37 weeks. In 18 
negative patient, 2 delivered as preterm(p<0.005). Sensitivity was 
89.5%, specificity was 94.1%, positive predictive valuewas 94.4%, 
negative predictive value was 88.9% 
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8.RICARDO GOMEZ  AND ASSOCIATES; 
Cervicovaginal  fibronectin improves the prediction of preterm delivery 
based on sonographic cervical length in patient with preterm labor 
Aim of this study was to assess the efficacy of USG  
measurment of cervical length and vaginal FFN to predict the preterm 
labor. It is a prospective study.214 patient with preterm contraction 
(22 to 35 weeks) and cervical dilatation less than 3 cm were included 
in this study. 
Outcome was assessed in terms of delivery within the 48 hours, 
7 days, 14 days of admission and delivery less than 32 and 35weeks. 
Admission to delivery interval was also calculated. 
This study was conducted in soterodelrio hospital, chile in1998 
to 2002. Transvaginal usg was used to assess  the cervical  length. 
Fluid in posterior fornix was collected for fetal fibronectin 
assessment. It was collected before digital examination and 
transvaginal examination. The concentration of 50 microgram per ml 
was indicative of positive test. 
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 Statistical analysis was done by chisquare test, logistic 
regression and survival analysis. Results shows preterm delivery less 
than 35 weeks was twenty percent, preterm delivery within 48 hours 
was 7.9 percent, within 7 days-13 %, within 14 days was 15.8%, ROC 
curve analysis shows there was a significant relationship between the 
preterm delivery and cervical length and fetal fibronectin. { p< 0.01 }. 
The prediction of preterm delivery was improved by adding FFN test 
with cervical length.  
9.O.OLCITSU ETAL { 1992 }: 
Early prediction of preterm delivery by transvaginal ultrasonography: 
In his study use of transvaginal usg in the evaluation of cervix 
length was assessed. 130 high risk and 129 control patient was 
evaluated. Shortening of cervix by -1.5 sd or more was associated 
with increased risk of preterm delivery { p < 0.01 } .Dilated internal 
os more than 5 mm was associated with preterm delivery{ p < 0.01}  
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10.HUA SIENG TING AND ASSOCIATES: 
Comparision ofbedside test for prediction of preterm labor.ph igfbp-1 and 
fetal fibronectin. 
Aim of this study was to compare the effectiveness of bedside 
kits for both phIGFBP-1 and FFN for predicting preterm delivery. 
Patient with symptoms of preterm labor was included                 
(24 to34 weeks). Both tests  were performed. Antenatal corticosteroid 
and tocolytics were continued. 108 patient were included in this 
study. Among 108 , 95 patient had complete data for analysis. 
If both test was negative,the median gestational age at delivery 
was3 7.4 weeks. If phIGFBP-1 and FFN both were positive the 
median gestational age at delivery was 32.4 to 34.2 weeks (p<0.001) . 
If any one of the test was positive the admission delivery interval was 
shortened. 
If phIGFBP-1 test was positive the admission delivery interval 
2.8 weeks shorter than negative group(2.3weeks compared with 5.1 
weeks).(p<0.001). but if  FFN test is positive ,the median delivery 
intervals 1.8 weeks shorter than negative test result(3.3 weeks 
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compared with 5.1 weeks)(p=0.002). Both test had high negative 
predictive value in predicting delivery within 48 hrs, 7 and 14 
days(1.00,0.92,0.92 and 0.97,0.89,0.89) 
Conclusion of this study was both phIGFBP-1 and FFN were 
effective bedside test to predict the   preterm delivery in symptomatic 
women. But phIGFBP-1 has higher negative predictive value of 1.00 
in predicting the risk of delivery within 48 hrs. 
11. LOOKWOOD ET AL  
 Association between ffn in preterm labor patient &preterm delivery 
This study showed that negative result would ruleout labor 
within 7 days. Negative predictive value was 97-99.5%.positive 
predictive value was 15-25%.   So a positive test should not be 
interpreted as an indicator of labor. 
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12.D-PATERNOSTER ET AL(2001) 
Sonographic cervical length and ph igfbp-1 in cervical secretion inthe 
prediction of spontaneous preterm delivery 
  Aim of this study is to evaluate the efficacy of phIGFBP-1 test 
for predicting preterm delivery. It is a prospective study. 210 women 
were included (24 to 35 weeks) in this study. They were underwent 
phIGFBP-1 test and transvaginal cervical length measurement.                  
A multivariate logistic   regression model was used to analysis the 
statistics. The prevalence of preterm delivery in symptomatic women 
was 16%. 
The ROC curve showed that 26mm of cervical length was the 
best cutoff value for predicting preterm delivery.(sensitivity 86.4%, 
specificity 71.9%,positive predictive value34.5%, negative predictive 
value 96.8%). 
If cervical length less than 26mm, 34.5% patient was delivered 
as preterm. But only 3.2% patient delivered as preterm if cervical 
length more than 26mm (p<0.0001).The odds ratio was very high. 
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In phIGFBP-1 test the sensitivity was 52.9%, specificity was 
89.2, PPV -48.7%& NPV-90.8%. The logistic  regression of 
phIGFBP-1 was statistically significant in predicting preterm 
delivery.(p<0.0001). The odds ratio was 9.29%. 
 Multivariate analysis shows , the two variable were independent 
, so useful in combination to predict preterm delivery(p<0.0001). The 
specificity of cervical length <26mm was increased in the presence of 
positive phosphorylated IGFBP-1-test (96%). 
Conclusion of this study was her TVS of cervical length of 
>26mm and exposure to phosphorylated IGFBP 1 in symptomatic 
patient shows a low risk for preterm delivery. So we avoid 
unnecessary intervention. 
13. AIDAY AND COLLEAGUES 
Predicting PTL: evaluation of ILGFBP 1 as a bedside test 
 It is a prospective study conducted in kotamarudu hospital, 
O&G department. All symptomatic women (28-37 weeks ) were 
included. 50 patients were recruited .Finally 44 were included.39 had 
64 
 
negative results.5 had positive results. Among 39, 6 delivered within 
7 days. Among 5,3 delivered within 7 days. The sensitivity, 
specificity ,PPV, NPV were 33%,94%,60%and 80% in predicting pre 
term delivery within 7 days. 
The conclusion of this study was that the bedside test had high 
specificity & NPV. So it could be used as predictor in PTL within 7 
days of symptoms . 
It help to decide in utero transfer of this patients  in local 
settings. 
14.ARDA LAMBET & ASSOCIATES(2002): 
New rapid bed side test to predict preterm delivery: phosphorylated insulin 
like growth factor binding protein in cervical secretion. 
It is a prospective study . 36 symptomatic women (20 -36 
weeks) were included. The presence of cervical phosphorylated 
insulin like growth factor binding protein was assessed by immuno 
chromatography( new rapid bedside test kit). 
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         Out of 36, 18 had positive and 18 had negative results. In 
18 positive & 17 delivered as preterm, among 18 negative cases 
2 delivered as preterm ( P< 0.05).  The sensitivity, specificity, 
positive predictive value and negative predictive value in 
preterm labor were 89.5,94.1,94.4, 88.9%. But the test was used 
to detect delivery within 7 days the sensitivity, specificity 
positive predictive value, negative predictive value were 93.8 
,85%,83.3, 94%. 
Conclusion of his study was cervical detection of 
phosphorylated insulin like growth factor binding protein- I by 
immune chromatography is a rapid &highly applicable test to predict 
preterm delivery in symptomatic high risk. 
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AGE GROUP * PRETERM 
TABLE I a 
   PRETERM  
   0 1 Total 
AGE 
GROUP 
Less than 20 
years 
Count 10 8 18 
% within AGE 
GROUP 
55.6% 44.4% 100.0% 
% within 
PRETERM 
16.1% 21.1% 18.0% 
% of Total 10.0% 8.0% 18.0% 
20 to 30 
years 
Count 45 28 73 
% within AGE 
GROUP 
61.6% 38.4% 100.0% 
% within 
PRETERM 
72.6% 73.7% 73.0% 
% of Total 45.0% 28.0% 73.0% 
More than 
30 years 
Count 7 2 9 
% within AGE 
GROUP 
77.8% 22.2% 100.0% 
% within 
PRETERM 
11.3% 5.3% 9.0% 
% of Total 7.0% 2.0% 9.0% 
 Total Count 62 38 100 
% within AGE 
GROUP 
62.0% 38.0% 100.0% 
% within 
PRETERM 
100.0% 100.0% 100.0% 
% of Total 62.0% 38.0% 100.0% 
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Chi-Square Tests 
TABLE I b 
 
Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 1.272a 2 .529 
Likelihood Ratio 1.343 2 .511 
Linear-by-Linear 
Association 
1.068 1 .301 
McNemar-Bowker Test - - .b 
N of Valid Cases 100   
 
INTERPRETATION 
In 100 study patient, 18 patient belongs to <20 yrs. 73Patients 
belongsto 20 to 30 years of age. Most of the preterm (73.7%) Occurs  
in 20 to 30 years of age groups. P value was 0.529. So there was no 
statistical association  between the age group and preterm in this 
study. 
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The same result was shown as bar diagram.  
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OBSTETRIC SCORE * PRETERM 
TABLE II a 
   PRETERM  
   0 1 Total 
OBSTETRIC 
SCORE 
primi Count 35 22 57 
% within 
OBSTETRIC 
SCORE 
61.4% 38.6% 100.0% 
% within PRETERM 56.5% 57.9% 57.0% 
% of Total 35.0% 22.0% 57.0% 
multi Count 27 16 43 
% within 
OBSTETRIC 
SCORE 
62.8% 37.2% 100.0% 
% within PRETERM 43.5% 42.1% 43.0% 
% of Total 27.0% 16.0% 43.0% 
 Total Count 62 38 100 
% within 
OBSTETRIC 
SCORE 
62.0% 38.0% 100.0% 
% within PRETERM 100.0% 100.0% 100.0% 
% of Total 62.0% 38.0% 100.0% 
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Chi-Square Tests 
TABLE II b 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .020a 1 .887   
Continuity 
Correctionb 
.000 1 1.000 
  
Likelihood Ratio .020 1 .887   
Fisher's Exact Test    1.000 .527 
Linear-by-Linear 
Association 
.020 1 .888 
  
McNemar Test    .c  
N of Valid Cases 100     
INTERPRETATION; 
In 100 patients, 57 patient were primi. 43 patients  were multi. 
Primi constitutes  57.9% of preterm , multi constitutes 42.1% of 
preterm. P value was 0.527. There was no statistical significance 
between obstetric score and preterm in this study. 
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The bar chart shows the association between obstetrics score and 
preterm.  
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CERVICAL DILATATION * PRETERM 
TABLE III a 
   PRETERM  
   0 1 Total 
CERVICAL 
DILATATION 
Nil Count 24 1 25 
% within 
CERVICAL 
DILATATION 
96.0% 4.0% 100.0%
% within PRETERM 38.7% 2.6% 25.0% 
% of Total 24.0% 1.0% 25.0% 
1cm Count 27 18 45 
% within 
CERVICAL 
DILATATION 
60.0% 40.0% 100.0%
% within PRETERM 43.5% 47.4% 45.0% 
% of Total 27.0% 18.0% 45.0% 
2cm Count 10 19 29 
% within 
CERVICAL 
DILATATION 
34.5% 65.5% 100.0%
% within PRETERM 16.1% 50.0% 29.0% 
% of Total 10.0% 19.0% 29.0% 
3cm Count 1 0 1 
% within 
CERVICAL 
DILATATION 
100.0% .0% 100.0%
% within PRETERM 1.6% .0% 1.0% 
% of Total 1.0% .0% 1.0% 
 Total Count 62 38 100 
% within 
CERVICAL 
DILATATION 
62.0% 38.0% 100.0%
% within PRETERM 100.0% 100.0% 100.0%
% of Total 62.0% 38.0% 100.0%
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Chi-Square Tests 
TABLE III b 
 
Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 22.276a 3 .000 
Likelihood Ratio 26.482 3 .000 
Linear-by-Linear 
Association 
19.012 1 .000 
McNemar-Bowker 
Test 
. . .b 
N of Valid Cases 100   
 
INTERPRETATION; 
According to cervical dilatation, 25 patients had no dilatation. In 
25,2.6% delivered as preterm. 45patients had 1cm dilatation. out 
ofthis, 47.4% had preterm delivery.29 patients had 2cm dilatation. 
Out of this 50% delivered as preterm. So most of the preterm occur in 
1 to 2 cmdilatation. In this study there was a statistical significance 
between cervical dilatation and preterm.(p-0.000) 
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TEST RESULT * PRETERM 
TABLE IV a 
   PRETERM  
   0 1 Total 
TEST 
RESULT 
negat
ive 
Count 59 6 65 
% within TEST 
RESULT 
90.8% 9.2% 100.0% 
% within 
PRETERM 
95.2% 15.8% 65.0% 
% of Total 59.0% 6.0% 65.0% 
positi
ve 
Count 3 32 35 
% within TEST 
RESULT 
8.6% 91.4% 100.0% 
% within 
PRETERM 
4.8% 84.2% 35.0% 
% of Total 3.0% 32.0% 35.0% 
 Total Count 62 38 100 
% within TEST 
RESULT 
62.0% 38.0% 100.0% 
% within 
PRETERM 
100.0% 100.0% 100.0% 
% of Total 62.0% 38.0% 100.0% 
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Chi-Square Test 
TABLE IVb 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 65.242a 1 .000   
Continuity 
Correctionb 
61.800 1 .000 
  
Likelihood Ratio 72.317 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear 
Association 
64.589 1 .000 
  
McNemar Test    .508c  
N of Valid Cases 100     
INTERPRETATION; 
In this study, among the 100 patient, 65 were test negative. Out 
of this only 15.8% delivered as preterm. Another 35 patient were test  
positive . Out of this 35  positive patient 84.2% delivered as preterm. 
This study shows , There was a statistical significance between the 
test and preterm.(P-0.000) 
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NICU ADMISSION * PRETERM 
TABLE V a 
   PRETERM  
   0 1 Total 
NICU 
ADMISSION
no Count 62 18 80 
% within NICU 
ADMISSION 
77.5% 22.5% 100.0%
% within PRETERM 100.0% 47.4% 80.0% 
% of Total 62.0% 18.0% 80.0% 
yes Count 0 20 20 
% within NICU 
ADMISSION 
.0% 100.0% 100.0%
% within PRETERM .0% 52.6% 20.0% 
% of Total .0% 20.0% 20.0% 
 Total Count 62 38 100 
% within NICU 
ADMISSION 
62.0% 38.0% 100.0%
% within PRETERM 100.0% 100.0% 100.0%
% of Total 62.0% 38.0% 100.0%
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Chi-Square Tests 
TABLE V b 
 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 40.789a 1 .000   
Continuity 
Correctionb 
37.566 1 .000 
  
Likelihood Ratio 47.507 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear 
Association 
40.382 1 .000 
  
McNemar Test    .000c  
N of Valid Cases 100     
INTERPRETATION; 
In this study 20 babies were admitted in NICU, and all of them 
were delivered as preterm. 80 babies were  not admitted in NICU. Out 
of this 80only 22.5% delivered as preterm. So there was a statistical 
significance between NICU admissionand preterm(P-0.000) 
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AGE GROUP * TEST RESULT 
TABLE VI a 
   TEST RESULT  
   0 1 Total 
AGE 
GROUP 
LESS THAN 
20 YEARS 
Count 9 9 18 
% within AGE 
GROUP 
50.0% 50.0% 100.0%
% within TEST 
RESULT 
13.8% 25.7% 18.0% 
% of Total 9.0% 9.0% 18.0% 
20 TO 30 
YEARS 
Count 49 24 73 
% within AGE 
GROUP 
67.1% 32.9% 100.0%
% within TEST 
RESULT 
75.4% 68.6% 73.0% 
% of Total 49.0% 24.0% 73.0% 
MORE THAN 
30 YEARS 
Count 7 2 9 
% within AGE 
GROUP 
77.8% 22.2% 100.0%
% within TEST 
RESULT 
10.8% 5.7% 9.0% 
% of Total 7.0% 2.0% 9.0% 
 Total Count 65 35 100 
% within AGE 
GROUP 
65.0% 35.0% 100.0%
% within TEST 
RESULT 
100.0% 100.0% 100.0%
% of Total 65.0% 35.0% 100.0%
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Chi-square test 
TABLE VI b 
 
Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 2.571a 2 .277 
Likelihood Ratio 2.539 2 .281 
Linear-by-Linear 
Association 
2.463 1 .117 
McNemar-Bowker 
Test 
. . .b 
N of Valid Cases 100   
INTERPRETATION;  
In this study 73% patient constitute 20 to 30 yrs of age group. 
Out of 73%, 24% had test positive. In less than 20 yrs of age group  
out of 18%, 9% had test positive. according to this study there was no 
statistical association between age group and test result.(P-0.277) 
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The bar diagram shows the association between the age group and test  
result.  
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OBSTETRIC SCORE * TEST RESULT 
TABLE VII a 
   TEST RESULT  
   0 1 Total 
OBSTETRIC 
SCORE 
primi Count 37 20 57 
% within 
OBSTETRIC 
SCORE 
64.9% 35.1% 100.0% 
% within TEST 
RESULT 
56.9% 57.1% 57.0% 
% of Total 37.0% 20.0% 57.0% 
multi Count 28 15 43 
% within 
OBSTETRIC 
SCORE 
65.1% 34.9% 100.0% 
% within TEST 
RESULT 
43.1% 42.9% 43.0% 
% of Total 28.0% 15.0% 43.0% 
 Total Count 65 35 100 
% within 
OBSTETRIC 
SCORE 
65.0% 35.0% 100.0% 
% within TEST 
RESULT 
100.0% 100.0% 100.0% 
% of Total 65.0% 35.0% 100.0% 
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Chi-Square Tests 
TABLE VII b 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .000a 1 .983   
Continuity 
Correctionb 
.000 1 1.000
  
Likelihood Ratio .000 1 .983   
Fisher's Exact Test    1.000 .577
Linear-by-Linear 
Association 
.000 1 .983
  
McNemar Test    .c  
N of Valid Cases 100     
INTERPRETATION; 
In this study out of 100 patient , 35 patient were test positive. In 
This 35, 57.1% were primi, and 42.9% were multi .The p value was 
0.577.so  there was no statistical association between obstetrics score 
and test result.  
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CERVICAL DILATATION * TEST RESULT 
TABLE VIII a 
   TEST RESULT  
   0 1 Total 
CERVICAL 
DILATATION 
NIL Count 25 0 25
% within CERVICAL 
DILATATION 
100.0% .0% 100.0%
% within TEST 
RESULT 
38.5% .0% 25.0%
% of Total 25.0% .0% 25.0%
1CM Count 26 19 45
% within CERVICAL 
DILATATION 
57.8% 42.2% 100.0%
% within TEST 
RESULT 
40.0% 54.3% 45.0%
% of Total 26.0% 19.0% 45.0%
2CM Count 13 16 29
% within CERVICAL 
DILATATION 
44.8% 55.2% 100.0%
% within TEST 
RESULT 
20.0% 45.7% 29.0%
% of Total 13.0% 16.0% 29.0%
3CM Count 1 0 1
% within CERVICAL 
DILATATION 
100.0% .0% 100.0%
% within TEST 
RESULT 
1.5% .0% 1.0%
% of Total 1.0% .0% 1.0%
 Total Count 65 35 100
% within CERVICAL 
DILATATION 
65.0% 35.0% 100.0%
% within TEST 
RESULT 
100.0% 100.0% 100.0%
% of Total 65.0% 35.0% 100.0%
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Chi-Square Tests 
TABLE VIII b 
 
Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-
Square 
20.219a 3 .000
Likelihood Ratio 28.308 3 .000
Linear-by-Linear 
Association 
15.409 1 .000
McNemar-
Bowker Test 
. . .b
N of Valid Cases 100   
INTERPRETATION; 
Out of 35 positive patient ,54.3% had 1Cmcervical dilatation,45.7% 
had 2 cm cervical  dilatation. 99% test positive patient had 1-2cm 
cervical dilatation .P value was 0.000. There was a significantstatistical  
association between test result and cervical dilatation in this study. 
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NICU ADMISSION * TEST RESULT 
TABLE IX a 
   TEST RESULT  
   0 1 Total 
NICU 
ADMISSION 
NO Count 63 17 80 
% within NICU 
ADMISSION 
78.8% 21.3% 100.0%
% within TEST 
RESULT 
96.9% 48.6% 80.0% 
% of Total 63.0% 17.0% 80.0% 
YES Count 2 18 20 
% within NICU 
ADMISSION 
10.0% 90.0% 100.0%
% within TEST 
RESULT 
3.1% 51.4% 20.0% 
% of Total 2.0% 18.0% 20.0% 
 Total Count 65 35 100 
% within NICU 
ADMISSION 
65.0% 35.0% 100.0%
% within TEST 
RESULT 
100.0% 100.0% 100.0%
% of Total 65.0% 35.0% 100.0%
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Chi-Square Tests 
TABLE IX b 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 33.242a 1 .000   
Continuity 
Correctionb 
30.288 1 .000
  
Likelihood Ratio 33.726 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear 
Association 
32.909 1 .000
  
McNemar Test    .001c  
N of Valid Cases 100     
INTERPRETATION; 
Out of 65 negative test patient only 10% of babies were  
admitted in NICU. But in 35 positive test patients 90% babies were  
admitted in NICU.P value was 0.000. So there was a statistical 
significant between NICU admission and test result in this study. 
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Group Statistics 
TABLE X  
 
TEST RESULT N Mean 
Std. 
Deviation 
Std. Error 
Mean 
WEGHIT OF 
BABY 
1 35 1.923 .5621 .0950 
0 65 2.822 .3955 .0491 
APGAR 1 
MIN 
1 35 5.49 1.853 .313 
0 65 6.95 .959 .119 
APGAR 5 
MIN 
1 35 7.03 1.524 .258 
0 65 8.18 .682 .085 
 
INTERPRETATION 
The mean birth weight of the baby in test positive patient was 
1.9 kg. The mean birth weight of the baby in test negative patient was 
2,8 kg The one minute and 5 minute apgar in test positive patient 
were 5 & 6 The one minute and 5 minute apgar in test negative  
patient were 7 & 8 
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ROC curve 
Variable CERVICAL_LENGTH 
CERVICAL LENGTH 
Classification variable PRETERM 
PRETERM 
  
 
Sample size  100 
Positive group : PRETERM = 1 38 
Negative group PRETERM = 0 62 
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 Criterion : ≤2.5
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Area under the ROC curve (AUC)  
Area under the ROC curve (AUC) 0.901528 
Standard Errora 0.0288 
95% Confidence intervalb 0.825637 to 0.952080 
z statistic 13.924 
Significance level P (Area=0.5) <0.0001 
 
 Youden index 
  
Youden index J 0.7156 
Associated criterion ≤2.5 
 
 Criterion values and coordinates of the ROC curve[Hide] 
Criterion Sensitivity 95% CI Specificity 95% CI +LR -LR 95% CI
<1.5 0.00 0.0 -
 9.3 
100.00 94.2 -
 100.0 
 1.00 0.0 -
 9.3 
≤1.8 23.68 11.4 -
 40.2 
100.00 94.2 -
 100.0 
 0.76 11.4 -
 40.2 
≤2 71.05 54.1 -
 84.6 
87.10 76.1 -
 94.3 
5.51 0.33 54.1 -
 84.6 
≤2.2 71.05 54.1 -
 84.6 
85.48 74.2 -
 93.1 
4.89 0.34 54.1 -
 84.6 
≤2.3 73.68 56.9 -
 86.6 
85.48 74.2 -
 93.1 
5.08 0.31 56.9 -
 86.6 
≤2.5 97.37 86.2 -
 99.9 
74.19 61.5 -
 84.5 
3.77 0.035 86.2 -
 99.9 
≤2.8 97.37 86.2 -
 99.9 
58.06 44.8 -
 70.5 
2.32 0.045 86.2 -
 99.9 
≤3 100.00 90.7 -
 100.0 
17.74 9.2 -
 29.5 
1.22 0.00 90.7 -
 100.0 
≤3.5 100.00 90.7 -
 100.0 
0.00 0.0 -
 5.8 
1.00  90.7 -
 100.0 
 
96 
 
  
 
Regression 
Dependent Y FINAL_GES._AGE 
FINAL GES. AGE 
Independent X CERVICAL_LENGTH 
CERVICAL LENGTH 
 
Sample size 100 
Coefficient of determination R2 0.4734 
Residual standard deviation 2.0614 
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  Regression Equation 
y = 28.1881  +  3.3890  x   
Parameter Coefficient Std. Error 95% CI t P 
Intercept 28.1881 0.9426 26.3176 to 30.0586 29.9061 <0.0001 
Slope 3.3890 0.3611 2.6724 to 4.1056 9.3852 <0.0001 
  
 Analysis of Variance 
Source DF Sum of Squares Mean Square 
Regression 1 374.3067 374.3067 
Residual 98 416.4533 4.2495 
 
  
F-ratio 88.0820 
Significance level P<0.001 
  
 Correlation 
Variable Y FINAL_GES._AGE 
FINAL GES. AGE 
Variable X CERVICAL_LENGTH 
CERVICAL LENGTH 
 
Sample size 100 
Correlation coefficient r 0.6880 
Significance level P<0.0001 
95% Confidence interval for r 0.5684 to 0.7791 
 
Sample size 100 
Correlation coefficient r 0.6880 
Significance level P<0.0001 
95% Confidence interval for r 0.5684 to 0.7791 
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ROC curve 
Variable CERVICAL_LENGTH 
CERVICAL LENGTH 
Classification variable PRETERM 
PRETERM 
 
Sample size  65 
Positive group :   PRETERM = 1 6 
Negative group :   PRETERM = 0 59 
  
  
Disease prevalence (%) unknown 
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Area under the ROC curve (AUC)  
Area under the ROC curve (AUC) 0.779661 
Standard Errora 0.0881 
95% Confidence intervalb 0.659615 to 0.873026 
z statistic 3.175 
Significance level P (Area=0.5) 0.0015 
  
 Youden index 
Youden index J Youden index J 
Associated criterion Associated criterion 
  
  
Criterion values and coordinates of the ROC curve[Hide] 
Criterion Sensitivity 95% CI Specificity 95% CI +LR -LR 
<2 0.00 0.0 -
 9.3 
100.00 94.2 -
 100.0 
 1.00 
≤2 23.68 11.4 -
 40.2 
100.00 94.2 -
 100.0 
 0.76 
≤2.2 71.05 54.1 -
 84.6 
87.10 76.1 -
 94.3 
5.51 0.33 
≤2.5 71.05 54.1 -
 84.6 
85.48 74.2 -
 93.1 
4.89 0.34 
≤2.8 73.68 56.9 -
 86.6 
85.48 74.2 -
 93.1 
5.08 0.31 
≤3 97.37 86.2 -
 99.9 
74.19 61.5 -
 84.5 
3.77 0.035 
≤3.5 97.37 86.2 -
 99.9 
58.06 44.8 -
 70.5 
2.32 0.045 
<2 100.00 90.7 -
 100.0 
17.74 9.2 -
 29.5 
1.22 0.00 
≤2 100.00 90.7 -
 100.0 
0.00 0.0 -
 5.8 
1.00  
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 Regression 
Dependent Y FINAL_GES._AGE 
FINAL GES. AGE 
Independent X CERVICAL_LENGTH 
CERVICAL LENGTH 
 
Sample size 65 
Coefficient of determination R2 0.1092 
Residual standard deviation 1.4950 
 
  Regression Equation 
y = 35.2994  +  1.1141  x   
  
Criterion Sensitivity Std. Error 95% CI t P 
Intercept 35.2994 1.1477 33.0058 to 37.5929 30.7564 <0.0001
Slope 1.1141 0.4010 0.3128 to 1.9154 2.7783 0.0072
  
Analysis of Variance 
 Source DF Sum of Squares Mean Square 
Regression 1 17.2525 17.2525 
Residual 63 140.8090 2.2351 
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F-ratio 7.7190 
Significance level P=0.007 
 
  
Correlation 
Variable Y FINAL_GES._AGE 
FINAL GES. AGE 
Variable X CERVICAL_LENGTH 
CERVICAL LENGTH 
 
Sample size 65 
Correlation coefficient r 0.3304 
Significance level P=0.0072 
95% Confidence interval for r 0.09406 to 0.5315 
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This ROC curve shows, in test negative patient, the cervical 
length measurement was less than 2.5 cm the sensitivity and 
specificity to predict preterm were 83.3 and 76.3%The final mean 
gestational age was 38 weeks.(p=0.0072) 
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ROC curve 
Variable CERVICAL_LENGTH 
CERVICAL LENGTH 
Classification variable PRETERM 
PRETERM 
 
Sample size   35 
Positive group :   PRETERM = 1 32 
Negative group : PRETERM = 0 3 
 
  
Disease prevalence (%) unknown 
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  Area under the ROC curve (AUC)  
  
Area under the ROC curve (AUC)  0.937500 
Standard Errora 0.0390 
95% Confidence intervalb 0.800906 to 0.991224 
z statistic 11.212 
Significance level P (Area=0.5) <0.0001 
 
  
Youden index 
Youden index J 0.8125 
Associated criterion ≤2.3 
  
 
Criterion values and coordinates of the ROC curve[Hide] 
Criterion Sensitivity 95% CI Specificity 95% CI +LR -LR
<1.5 0.00 0.0 -
 10.9
100.00 29.2 -
 100.0
  1.00
≤2.3 81.25 63.6 -
 92.8
100.00 29.2 -
 100.0
  0.19
≤2.5 100.00 89.1 -
 100.0
33.33 0.8 -
 90.6
1.50 0.00
≤2.7 100.00 89.1 -
 100.0
0.00 0.0 -
 70.8
1.00  
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Regression 
Dependent Y FINAL_GES._AGE 
FINAL GES. AGE 
Independent X CERVICAL_LENGTH 
CERVICAL LENGTH 
 
Sample size 35 
Coefficient of determination R2 0.1996 
Residual standard deviation 1.8532 
  
  
Regression Equation 
y = 28.6372  +  2.5415  x   
Parameter Coefficient Std. Error 95% CI t P Parameter
Intercept 28.6372 1.8269 24.9204 to 32.3540 15.6757 <0.0001 Intercept 
Slope 2.5415 0.8860 0.7389 to 4.3440 2.8685 0.0071 Slope 
  
 Analysis of Variance 
Source DF Sum of Squares Mean Square
Regression 1 28.2611 28.2611
Residual 33 Sum of Squares 3.4345
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Correlation 
Variable Y FINAL_GES._AGE 
FINAL GES. AGE 
  
Variable X CERVICAL_LENGTH 
CERVICAL LENGTH 
 
Sample size 35 
Correlation coefficient r 0.4467 
Significance level P=0.0071 
95% Confidence interval for r 0.1333 to 0.6789 
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TES TRESULT VS PRETERM 
 
TEST RESULT 
 
PRETERM 
 
TERM 
 
 
 
POSITIVE 
 
32 
 
3 
 
 
35 
 
 
NEGATIVE 
 
 
 
6 
 
 
59 
 
 
65 
 38 62  
 
INTERPERTATION 
Sensitivity     : 84.21% 
 Specificity     : 95.66% 
Positive predictive value : 91.43% 
Negative predictive value : 90.77% 
Diagnostic accuracy of the test : 91% 
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CERVICAL LENGTH VS PRETERM 
 
CERVICAL 
LENGTH 
 
PRETERM 
 
TERM 
 
 
 
< 2.5CM 
 
 
37 
 
 
16 
 
 
53 
 
 
>2.5CM 
 
 
1 
 
46 
 
 
47 
 
 
 
 
 
38 
 
62 
 
 
 
 
 
INTERPRETATION 
Sensitivity : 97.37% 
Specificity : 74.19% 
Positive predictive value   : 69.81% 
Negative predictive value       : 97.87% 
Diagnostic accuracy of cervical length : 83% 
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DISCUSSION 
 In this study 100 women with preterm pains and less than 3cm  cervical 
dilatation were selected 
 General and obstetrics examination was done for all Cases including 
pelvic examination. 
 Cervical swab for phIGFBP-1 was taken for all patient. The test was done 
by using bedside kit by immunoenzymetric assay. Thetest kit shows two 
dark line if phIGFBP-1 level more than10microgram. It was considered 
as positive. 
 In 100 patient 38 patient delivered as preterm.35 cases were phIGFBP-1 
test positive. Out of 35, 32 was delivered as preterm. 65 cases were test 
negative. Out of 65, 6 cases were delivered as preterm 
 73% of the patient were in the age group of 20-30 yrs,with 
average of 24 yrs.57.9%were primi, 42.1% were multi. 
 NICU admission was more in preterm(100%) compared to 
term deliveries. The main cause of admission was low birth weight and 
respiratory distress syndrome. 
 In 35 test positive patient, 96% patient had 1-2 cm cervicaldilatation(p-
0.0001).There was a statistical significance between the test and preterm 
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delivery, cervical dilatation and NICU admission In this study The 
average weight of the baby in test positive patient was 1.9 kg 
 The sensitivity and specificity of cervical length to predict preterm labor 
was 97.4% and 79.2%.The cervical length cut off   was 2.5 cm. if cervical 
length was 2.5 cm ,the mean final    gestational age was 35-36 weeks. If it 
was less than 2 cm, the  mean final gestational age was 32-33 weeks.                 
So cervical length measurement was a independent predictor of preterm 
delivery. 
 If the test was negative and cervical length was2.5 cm, the sensitivity of 
the test to predict preterm delivery was 83.3%, specificity was 76.3%. 
 
 If the test was positive and cervical length was less than 2.3 and the test 
was positive, the sensitivity was 81.2% and specificity was 100%. if 
patient had less than 2.3 cm cervical length and the test was positive, she 
more likely delivered as preterm 
 
 In test positive patient(35), most of them delivered less than 35 weeks of 
gestation. Mean final gestational age in test positive was 33.3 weeks.so 
there was a strong association between gestational age at delivery and 
cervical lehgth in test positive patient. 
 The ROC curve showed that 2.5 cm of cervical length was the best cutoff 
value for predicting preterm labor.                                   
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 The positive and negative predictive value of this test to predict preterm 
delivery were 91.43% and 90.77% 
 The positive and negative predictive value of the cervical 
Length (<2.5cm) to predict preterm delivery were 69.81% and 97.87% 
 According to this study the diagnostic accuracy of cervical length was 
83% . the diagnostic accuracy of phIGFBP-1 was 91%  
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CONCLUSION 
 According to this  study the phIGFBP-1 measurement in cervical 
secretion is a rapid and highly applicable test to predict preterm delivery 
in symptomatic women 
 Cervical length measurement is also an independent predictor for preterm 
delivery. The best cutoff value of cervical length was 2.5 cm 
 When the test was combined with cervical length Measurement                     
(< 2.5CM )to predict preterm delivery, the sensitivity and specificity were 
increased. 
 The diagnostic accuracy was more in the test group (91% than cervical 
length measurement (83%) to predict preterm delivery. 
 So the phIGFBP-1 test can be used as bedside kit test to predict preterm 
delivery solely or in combination with cervical length measurement. 
 So this test can be used to avoid unnecessary obstetrics intervention like 
tocolysis and hospitalization. In positive patient it will help to decide 
inutero transfer of the patient to tertiary care level. 
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PROFORMA 
1. NAME :
2. AGE :
3. IP NO :
4. PARITY :
5. EDUCATION :
6. DATE OF ADMISSION :
7. GESTATIONAL AGE :
8. ANY HIGH RISK :
9. HISTORY :
 painduration  
 draining pv 
 h/o urinary tract infection 
 h/o vaginal bleeding 
 previous cesarean       
10.PER ABDOMINAL EXAMINATION: 
11.PER VAGINAL EXAMINATION      : 
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 Effacement 
 Dilatation 
 Membrane statu 
12.IGFBP-1                                  : 
 Positive/ negative 
13. TYPE OF FOLLOW UP:  
 Clinical 
 Phone 
14. TIME OF FOLLOW UP: 
 First 7 days 
 Up to 37weeks 
 Tll delivery 
15. DELIVARY: 
 Within7 day 
 Before 37 weeks 
 After 37 weeks 
 
 
  
S.NO IP.NO OBSTETRIC SCORE GESTATIONAL AGE CERVICAL DILATATION CERVICAL LENGTH TEST RESULT
1 3654 p 32 1 3 n
2 5342 m 34 2 1.5 p
3 5466 p 30 1 3 n
4 7543 m 33 2 2 n
5 8345 m 31 2 1.5 p
6 7655 p 35 0 3 n
7 7621 p 29 1 2.7 n
8 5439 p 33 1 2 p
9 6755 p 34 2.5 2.8 n
10 7433 m 32 0 2.8 n
11 8655 p 34 2 1.8 p
12 8932 p 35 0 3.5 n
13 8691 m 30 2 2 p
14 9231 m 32 2 2 n
15 9345 m 33 2 2 n
16 9511 p 34 2 3 n
17 9793 p 29 2 1.5 p
18 9834 p 32 0 2.5 n
19 9718 m 34 1 2.5 p
20 10231 p 33 0 2.8 n
21 10726 p 31 0 3 n
22 10854 m 31 2 2 p
23 10781 m 33 1 2.8 n
24 10891 p 34 1 3 n
25 11239 p 32 2 2 p
26 11485 p 30 0 2.7 N
27 11632 M 35 2 2.5 p
28 11740 m 32 2 2.2 n
29 11876 m 33 2 2.8 n
30 11809 p 34 0 3.5 n
31 11978 p 31 0 3 n
32 11954 p 33 1 2.5 p
33 12013 m 34 2 1.8 p
34 12145 m 35 2 2 n
35 12278 p 32 0 3.5 n
36 12265 p 33 1 2.7 n
37 12311 p 33 1 2.5 p
38 12376 m 34 2 2.5 p
39 12433 m 36 2 2 n
40 12480 m 31 1 3 n
41 12541 p 34 1 2.5 p
42 12618 p 32 2 2 n
43 12679 m 35 2 2.5 n
44 12602 p 32 0 3.5 n
45 12700 p 33 1 2.3 p
46 12783 m 32 1 3 n
47 12831 m 30 1 3.5 n
48 12847 m 31 1 2.5 n
49 12915 p 33 1 1.5 p
50 12994 p 32 0 3 n
51 13015 p 34 0 3 n
52 13267 m 33 2 2.5 p
53 13302 m 30 1 3 n
54 13362 m 29 1 3.5 n
55 13409 p 32 1 2.7 p
56 13598 p 35 1 3 n
57 13631 m 35 1 2 p
58 13843 p 33 0 3.5 n
59 13901 p 33 1 3 n
60 14005 p 31 2 2 p
61 14461 m 34 2 2 n
62 14683 m 35 1 2 n
63 14830 p 33 1 2.5 p
64 15078 m 33 1 2.5 n
65 15294 p 32 0 3 n
66 15543 m 33 1 2 p
67 15571 m 35 1 3 n
68 15723 p 33 0 3 n
69 15800 p 34 1 2 p
70 15993 p 34 1 3 n
71 16203 p 28 1 2 p
72 16421 p 32 1 2 p
73 16459 p 35 1 2.5 n
74 16682 m 32 1 3 n
75 16707 m 33 1 2.5 n
76 16880 p 36 0 3 n
77 17046 p 35 2 2 p
78 17471 m 34 2 1.5 p
79 17639 m 34 2 2 n
80 17820 p 32 0 3 n
81 17935 p 34 0 3.5 n
82 18053 p 33 1 1.5 p
83 18360 m 34 2 2 p
84 18482 m 30 1 3 n
85 18567 m 29 1 2.5 n
86 18581 p 31 0 2.8 n
87 18674 p 33 0 3.5 n
88 18721 p 35 1 3 n
89 18870 p 33 1 2 p
90 19062 m 31 1 3.5 n
91 19276 p 34 1 2 p
92 19343 m 31 2 2 n
93 19654 m 32 2 1.5 p
94 20176 p 30 0 3 n
95 20452 p 33 0 3.5 n
96 21765 p 34 1 2 p
97 21862 m 33 0 3 n
98 21347 p 30 0 3 n
99 21654 m 33 1 2 p
100 21786 p 32 1 2.5 n
FINAL GES. AGE SEVERE PRETERM ASSO.MEDICAL CONDITION WEGHIT OF BABY NICU ADMISSION APGAR APGAR
39 0 0 2.8 n 7/10,8/10 7/10,8/11
35 0 1 2.1 n 6/10,8/10 6/10,8/11
38 0 0 2.7 n 7/10,8/10 7/10,8/11
40 0 0 3 n 8/10,9/10 8/10,9/11
32 1 0 1.2 y 5/10,6/10 5/10,6/11
39 0 1 3.2 n 7/10,8/10 7/10,8/11
38 0 2 2.6 n 7/10,9/10 7/10,9/11
34 0 0 2 n 6/10,7/10 6/10,7/11
39 0 0 3.1 n 7/10,8/10 7/10,8/11
37 0 0 2.5 n 6/10,8/10 6/10,8/11
34 0 0 2.3 y 3/10,6/10 3/10,6/11
38 0 0 2.5 n 6/10,8/10 6/10,8/11
30 1 1 1 y 3/10,5/10 3/10,5/11
37 0 0 2.4 n 6/10,8/10 6/10,8/11
39 0 0 2.7 n 7/10,8/10 7/10,8/11
36 0 0 2.4 y 4/10,6/10 4/10,6/11
29 1 0 0.8 y 2/10,4/10 2/10,4/11
36 0 0 2.8 n 6/10,7/10 6/10,7/11
38 0 0 2.9 n 8/10,9/10 8/10,9/11
40 0 0 2.9 n 7/10,8/10 7/10,8/11
41 0 1 2.9 n 8/10,9/10 8/10,9/11
32 1 2 0.9 y 2/10,4/10 2/10,4/11
39 0 0 3.2 n 7/10,8/10 7/10,8/11
38 0 0 3 n 8/10,9/10 8/10,9/11
32 0 1 1.4 y 4/10,6/10 4/10,6/11
39 0 0 2.8 N 7/10,8/10 7/10,8/11
35 0 0 2.2 n 6/10,8/10 6/10,8/11
37 0 2 2.5 n 7/10,8/10 7/10,8/11
39 0 0 2.9 n 7/10,8/10 7/10,8/11
40 0 0 3.3 n 8/10,9/10 8/10,9/11
37 0 0 2.6 n 8/10,9/10 8/10,9/11
33 0 0 1.9 y 5/10,6/10 5/10,6/11
35 0 2 2.2 n 7/10,9/10 7/10,9/11
38 0 0 2.9 n 8/10,9/10 8/10,9/11
39 0 0 2.8 n 6/10,8/10 6/10,8/11
40 0 1 3.2 n 7/10,8/10 7/10,8/11
38 0 0 2.7 n 7/10,8/10 7/10,8/11
34 0 2 2.1 y 5/10,6/10 5/10,6/11
39 0 0 2.9 n 7/10,8/10 7/10,8/11
37 0 2 2.5 n 8/10,9/10 8/10,9/11
35 0 0 2.3 n 6/10,7/10 6/10,7/11
36 0 1 2.2 n 7/10,8/10 7/10,8/11
37 0 0 2.8 n 7/10,8/10 7/10,8/11
40 0 0 3.4 n 7/101,8/10 7/101,8/11
34 0 0 2.1 y 3/10,6/10 3/10,6/11
39 0 1 2.9 n 7/10,8/10 7/10,8/11
40 0 2 3.2 n 8/10,9/10 8/10,9/11
39 0 0 2.5 n 8/10,9/10 8/10,9/11
33 0 0 1.7 y 5/10,6/10 5/10,6/11
40 0 0 3 n 7/10,8/10 7/10,8/11
38 0 1 3.1 n 7/10,9/10 7/10,9/11
34 0 0 1.8 y 5/10,7/10 5/10,7/11
40 0 0 3.4 n 7/10,8/10 7/10,8/11
37 0 0 2.5 n 7/10,8/10 7/10,8/11
37 0 2 2.6 n 8/10,9/10 8/10,9/11
39 0 0 3 n 7/10,8/10 7/10,8/11
35 0 2 2.3 n 6/10,8/10 6/10,8/11
40 0 0 3.5 n 7/10,9/10 7/10,9/11
39 0 0 2.8 n 7/10,8/10 7/10,8/11
31 1 0 1 y 3/10,5/10 3/10,5/11
36 0 0 2.2 n 7/10,8/10 7/10,8/11
38 0 2 2.9 n 7/10,8/10 7/10,8/11
34 0 0 2 n 7/10,8/10 7/10,8/11
37 0 0 2.4 n 8/10,9/10 8/10,9/11
39 0 0 2.8 n 8/10,9/10 8/10,9/11
34 0 2 2.1 n 6/10,8/10 6/10,8/11
38 0 0 2.4 n 7/10,8/10 7/10,8/11
40 0 0 3 n 7/10,8/10 7/10,8/11
35 0 0 2.3 n 8/10,9/10 8/10,9/11
37 0 0 2.9 n 8/10,9/10 8/10,9/11
29 1 0 0.6 y 2/10,4/10 2/10,4/11
33 1 2 1.8 y 4/10,6/10 4/10,6/11
36 0 0 2.3 n 6/10,7/10 6/10,7/11
38 0 0 2.5 n 7/10,8/10 7/10,8/11
40 0 0 2.9 n 8/10,9/10 8/10,9/11
41 0 1 3.8 n 8/10,9/10 8/10,9/11
35 0 0 2.6 n 7/10,9/10 7/10,9/11
34 0 2 2.3 n 7/10,8/10 7/10,8/11
38 0 0 2.9 n 7/10,8/10 7/10,8/11
40 0 0 2.5 n 6/10,8/10 6/10,8/11
39 0 1 2.9 n 7/10,8/10 7/10,8/11
33 0 0 1.8 y 6/10,7/10 6/10,7/11
35 0 0 2.2 n 7/10,8/10 7/10,8/11
37 0 2 2.7 n 7/10,8/10 7/10,8/11
32 1 0 1.4 y 3/10,6/10 3/10,6/11
39 0 0 3 n 6/10,7/10 6/10,7/11
41 0 0 3.9 n 7/10,8/10 7/10,8/11
40 0 0 3 n 7/10,8/10 7/10,8/11
34 0 0 2.2 n 8/10,9/10 8/10,9/11
38 0 2 2.7 n 6/10,8/10 6/10,8/11
35 0 0 2.2 n 7/10,8/10 7/10,8/11
38 0 0 2.8 n 7/10,8/10 7/10,8/11
33 0 0 1.4 y 4/10,6/10 4/10,6/11
38 0 0 3.4 n 7/10,8/10 7/10,8/11
40 0 0 2.9 n 8/10,9/10 8/10,9/11
35 0 2 2.1 n 7/10,8/10 7/10,8/11
39 0 0 2.2 n 4/10,7/10 4/10,7/11
37 0 0 2.7 n 7/10,9/10 7/10,9/11
34 0 0 2.2 n 7/10,8/10 7/10,8/11
40 0 0 2.9 n 8/10,9/10 8/10,9/11
